Andrew Buchanan

807 total citations
24 papers, 581 citations indexed

About

Andrew Buchanan is a scholar working on Psychiatry and Mental health, Physiology and Surgery. According to data from OpenAlex, Andrew Buchanan has authored 24 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Physiology and 5 papers in Surgery. Recurrent topics in Andrew Buchanan's work include Migraine and Headache Studies (8 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). Andrew Buchanan is often cited by papers focused on Migraine and Headache Studies (8 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). Andrew Buchanan collaborates with scholars based in United States, Australia and United Kingdom. Andrew Buchanan's co-authors include Louise Lombard, John H. Krege, Romaldas Mačiulaitis, Christian K. Schneider, Li Shen Loo, Tina Schmidt, Christopher K. Fairley, Eric P. F. Chow, Sherie A. Dowsett and Elena Rodríguez‐Rodríguez and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Neurology.

In The Last Decade

Andrew Buchanan

22 papers receiving 570 citations

Peers

Andrew Buchanan

PMH

PHYSI

PFM

SURGE

Geraint Fuller United Kingdom

Sara Ghaderi Norway

Emmanuelle Vincent France

Ismail Ibrahim Ismail Kuwait

Beau K. Nakamoto United States

Vincent Bouteloup France

Roger Mills United Kingdom

Mary Kaye Willian United States

S Narayanan United States

P. Duller Netherlands

Geraint Fuller United Kingdom

Andrew Buchanan

142 ×0.5

PMH

108 ×0.7

PHYSI

185 ×1.3

PFM

61 ×0.6

SURGE

54 ×0.6

Citations per year, relative to Andrew Buchanan Andrew Buchanan (= 1×) peers Geraint Fuller

Countries citing papers authored by Andrew Buchanan

Since Specialization

Citations

This map shows the geographic impact of Andrew Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Buchanan more than expected).

Fields of papers citing papers by Andrew Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Buchanan. The network helps show where Andrew Buchanan may publish in the future.

Co-authorship network of co-authors of Andrew Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Buchanan. A scholar is included among the top collaborators of Andrew Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Buchanan. Andrew Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aung, Ei T., Christopher K. Fairley, Deborah A. Williamson, et al.. (2023). Treponema pallidum PCR screening at mucosal sites of asymptomatic men who have sex with men taking HIV pre-exposure prophylaxis. Microbiology Spectrum. 11(5). e0079423–e0079423. 1 indexed citations

Ahmed, Zubair, Vincent T. Martin, Andrew Buchanan, et al.. (2021). Tolerability of Lasmiditan in Elderly Patients with Migraine (1814). Neurology. 96(15_supplement).

Chow, Eric P. F., Ian Denham, Tina Schmidt, et al.. (2021). Clinical Presentation of Incident Syphilis Among Men Who Have Sex with Men Taking HIV Pre-Exposure Prophylaxis in Melbourne, Australia. Clinical Infectious Diseases. 73(4). e934–e937. 9 indexed citations

Chow, Eric P. F., Jane S. Hocking, Jason J. Ong, et al.. (2021). Brief Report: Changes in PrEP Use, Sexual Practice, and Use of Face Mask During Sex Among MSM During the Second Wave of COVID-19 in Melbourne, Australia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 86(2). 153–156. 32 indexed citations

Leroux, Élizabeth, Andrew Buchanan, Louise Lombard, et al.. (2020). Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review. Advances in Therapy. 37(12). 4765–4796. 39 indexed citations

Lipton, Richard B., Louise Lombard, Dustin Ruff, et al.. (2020). Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study. The Journal of Headache and Pain. 21(1). 20–20. 30 indexed citations

Lombard, Louise, Wenyu Ye, Yongin Kim, et al.. (2020). A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication. The Journal of Headache and Pain. 21(1). 41–41. 46 indexed citations

Krege, John H., Paul Rizzoli, Emily Liffick, et al.. (2019). Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN. Cephalalgia. 39(8). 957–966. 51 indexed citations

Knievel, Kerry, Andrew Buchanan, Louise Lombard, et al.. (2019). Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans. Cephalalgia. 40(1). 19–27. 40 indexed citations

10.

Tepper, Stewart J., John H. Krege, Louise Lombard, et al.. (2019). Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials. Headache The Journal of Head and Face Pain. 59(7). 1052–1062. 29 indexed citations

11.

Krege, John H., et al.. (2019). Safety Findings from the Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan for Acute Treatment of Migraine (P1.10-009). Neurology. 92(15_supplement). 2 indexed citations

12.

Mao, Limin, Andrew Buchanan, Horas Wong, & Asha Persson. (2018). Beyond mere pill taking: SMS reminders for HIV treatment adherence delivered to mobile phones of clients in a community support network in Australia. Health & Social Care in the Community. 26(4). 486–494. 18 indexed citations

13.

Wietecha, Linda, David B. Clemow, Andrew Buchanan, et al.. (2016). Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials. CNS Neuroscience & Therapeutics. 22(7). 546–557. 7 indexed citations

14.

Nylander, Sven, S. KENNETH PEHRSSON, Tord Inghardt, et al.. (2015). A SPECIFIC ANTIDOTE FOR TICAGRELOR. Journal of the American College of Cardiology. 65(10). A253–A253. 1 indexed citations

15.

Tanaka, Yoko, et al.. (2015). Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic Factors. Therapeutic Innovation & Regulatory Science. 50(1). 91–100. 1 indexed citations

16.

Bangs, Mark E., Linda Wietecha, Shufang Wang, Andrew Buchanan, & Douglas K. Kelsey. (2014). Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine. Journal of Child and Adolescent Psychopharmacology. 24(8). 426–434. 41 indexed citations

17.

Buchanan, Andrew, et al.. (2013). Imaging of indeterminate pancreatic cystic lesions: A systematic review. Pancreatology. 13(4). 436–442. 54 indexed citations

18.

Mačiulaitis, Romaldas, et al.. (2012). Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive. Molecular Therapy. 20(3). 479–482. 71 indexed citations

19.

Caschera, Filippo, Mark A. Bedau, Andrew Buchanan, et al.. (2009). Automated Discovery of Novel Drug Formulations Using Predictive Iterated High Throughput Experimentation. PLoS ONE. 5(1). e8546–e8546. 22 indexed citations

20.

Bedau, Mark A., et al.. (2005). Evolutionary design of a DDPD model of ligation. ARCA (Università Ca' Foscari Venezia). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact